Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9428739rdf:typepubmed:Citationlld:pubmed
pubmed-article:9428739lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C1417811lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C1155437lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9428739lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9428739pubmed:issue3lld:pubmed
pubmed-article:9428739pubmed:dateCreated1998-2-2lld:pubmed
pubmed-article:9428739pubmed:abstractTextNatriuretic peptide receptor C (NPR-C) mRNA expression and ANP-binding activity via NPR-C are significantly down-regulated in HeLa cells with phorbol myristate acetate (PMA) treatment. Stabilization of the NPR-C mRNA by PMA indicated that down-regulation of its mRNA was mediated through negative transcriptional regulation. Despite the significant loss of the mRNA, reduction of NPR-C-specific ANP-binding activity after PMA exposure (4 h) was accompanied by a slight decrease in total NPR-C protein (with a 5% loss) and was also produced in the presence of actinomycin D or cycloheximide. The inhibitory effect of a long PMA exposure (18 h) paralleled with a decrease in total NPR-C protein is suggested to be dependent on reduction of de novo NPR-C synthesis. PMA-induced transcriptional and post-translational down-regulation of NPR-C was effectively reversible in the presence of the protein kinase C inhibitor GF109203X. These findings demonstrate that protein kinase C activation down-regulated NPR-C expression through transcriptional and post-translational pathways and that immediate functional receptor loss was mediated via a post-translational mechanism, such as enhanced receptor internalization.lld:pubmed
pubmed-article:9428739pubmed:languageenglld:pubmed
pubmed-article:9428739pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:citationSubsetIMlld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9428739pubmed:statusMEDLINElld:pubmed
pubmed-article:9428739pubmed:monthDeclld:pubmed
pubmed-article:9428739pubmed:issn0014-5793lld:pubmed
pubmed-article:9428739pubmed:authorpubmed-author:OmoriKKlld:pubmed
pubmed-article:9428739pubmed:authorpubmed-author:AkatsukaHHlld:pubmed
pubmed-article:9428739pubmed:authorpubmed-author:YanakaNNlld:pubmed
pubmed-article:9428739pubmed:issnTypePrintlld:pubmed
pubmed-article:9428739pubmed:day1lld:pubmed
pubmed-article:9428739pubmed:volume418lld:pubmed
pubmed-article:9428739pubmed:ownerNLMlld:pubmed
pubmed-article:9428739pubmed:authorsCompleteYlld:pubmed
pubmed-article:9428739pubmed:pagination333-6lld:pubmed
pubmed-article:9428739pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:meshHeadingpubmed-meshheading:9428739-...lld:pubmed
pubmed-article:9428739pubmed:year1997lld:pubmed
pubmed-article:9428739pubmed:articleTitleProtein kinase C activation down-regulates natriuretic peptide receptor C expression via transcriptional and post-translational pathways.lld:pubmed
pubmed-article:9428739pubmed:affiliationLead Generation Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka, Japan.lld:pubmed
pubmed-article:9428739pubmed:publicationTypeJournal Articlelld:pubmed